Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

CONCLUSIONS: Centanafadine provides statistically significant and clinically meaningful improvement in ADHD symptoms with generally acceptable tolerability, supporting its role as a non-stimulant treatment option. Further long-term and comparative trials are warranted.

via https://pubmed.ncbi.nlm.nih.gov/42267239/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20260616011005&v=2.20.0